Recombinant IL5 (Mepolizumab Biosimilar) anticorps

N° du produit ABIN7487818

Cet anticorps Mammalian Cells Monoclonal détecte spécifiquement IL5 (Mepolizumab Biosimilar) dans ELISA. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Recombinant IL5 (Mepolizumab Biosimilar) anticorps (ABIN7487818)

Antigène: IL5 (Mepolizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Mammalian Cells

Clonalité: Monoclonal

Conjugué: Cet anticorp IL5 (Mepolizumab Biosimilar) est non-conjugé

Application: ELISA

Classe de qualité: Research Grade

Détail du produit anti-IL5 (Mepolizumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Mepolizumab Biosimilar - Anti-IL5 mAb

Attributs du produit: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Buffer: PBS pH 7.5

Stock: -80 °C

Stockage commentaire: store at -80°C

Détails sur IL5 (Mepolizumab Biosimilar)

Antigène: IL5 (Mepolizumab Biosimilar)

Classe de substances: Biosimilar

Sujet: SB-240563
Mepolizumab is a fully humanized recombinant IgG1 kappa monoclonal antibody directed against IL-5 produced in Chinese hamster ovary cells. (EGPA) and eosinophilia syndrome (HES). The pathogenesis of eosinophils is complex, but IL-5 is considered a key eosinophilic factor, involved in the differentiation, recruitment, activation and prolonged survival of eosinophils in peripheral tissues. Activated eosinophils further stimulate the inflammatory response, and also induce tissue damage and promote fibrosis, all of which contribute to the multifactorial symptoms of eosinophilic disease. Mepolizumab is used to treat severe asthma.

Numéro CAS: 196078-29-2